Article

(2020) Deep learning for electronic health records: A comparative review of multiple deep neural architectures. Journal of Biomedical Informatics.

(2020) Intensive Blood Pressure Lowering and Risk of Diabetes: Friend or Foe? Hypertension (Dallas, Tex. : 1979). pp. 293-294. ISSN 1524-4563 (Electronic) 0194-911X (Linking)

(2020) Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects. European Heart Journal. p. 1942. ISSN 0195-668X

(2020) Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects. European heart journal. p. 1942. ISSN 15229645

(2020) Mendelian randomization of plasma lipids and aortic valve stenosis: the importance of outlier variants and population stratification. European heart journal. pp. 2714-2715. ISSN 15229645

(2020) Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study. European heart journal. ISSN 1522-9645 (Electronic) 0195-668X (Linking)

(2019) BLOOD PRESSURE AND RISK OF VENOUS THROMBOEMBOLISM: A LARGE-SCALE PROSPECTIVE COHORT ANALYSIS AND A MENDELIAN RANDOMISATION STUDY. Journal of Hypertension. E95-E95. ISSN 0263-6352

(2019) Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients. PLoS medicine. e1002805. ISSN 15491676

(2019) Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. pp. 1757-1767. ISSN 1473-5598 (Electronic) 0263-6352 (Linking)

(2019) Heterogeneity Between Genetic Variants as a Proxy for Pleiotropy in Mendelian Randomization-Reply. JAMA cardiology. ISSN 2380-6591 (Electronic)

(2019) Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies. Heart (British Cardiac Society). ISSN 1468-201X (Electronic) 1355-6037 (Linking)

(2019) Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC). BMJ Open. ISSN 20446055

(2019) Long-Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large-Scale Routine Electronic Health Records. Journal of the American Heart Association.

(2019) Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study. JAMA Cardiol. ISSN 2380-6591 (Electronic)

(2018) Elevated blood pressure and risk of aortic valve disease: A cohort analysis of 5.4 million UK adults. European Heart Journal. pp. 3596-3603.

(2018) Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study. PLoS medicine. e1002513. ISSN 1549-1676 (Electronic) 1549-1277 (Linking)

(2018) Resistant hypertension in times of changing definitions and treatment recommendations. Heart (British Cardiac Society). ISSN 1468-201X (Electronic) 1355-6037 (Linking)

(2017) Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS medicine. e1002404. ISSN 1549-1676 (Electronic) 1549-1277 (Linking)